Multiphze Selected Among 65 Breakout Medtech Startup Companies in MedTech Innovator 2025 Cohort
Los Angeles — June 10, 2025 – MedTech Innovator (MTI), the world’s largest and most impactful accelerator for medical technology startups, today announced that Multiphze is among 65 companies selected for its highly competitive 2025 Accelerator Cohort. These companies, representing the top 4% of nearly 1,500 global applicants, will participate in MTI’s flagship four-month program designed to de-risk innovation and accelerate the path to U.S. market success.
The 2025 cohort includes early and mid-stage medical device, diagnostic, and digital health companies that will receive unparalleled mentorship, strategic guidance, and access to MTI’s world-class ecosystem of industry-leading strategic manufacturers, investors, providers, payers, patients, and other industry stakeholders. Participants also join the highest-performing peer network in the sector. MTI alumni have collectively brought over 400 products to market and raised $10 billion in follow-on funding. Companies in this year’s cohort will compete for a share of $800,000 in non-dilutive funding, with winners selected by audience vote at major industry conferences.
“MedTech Innovator’s accelerator is a comprehensive platform for risk mitigation and value creation that helps the world’s most promising medtech startups become investable,” said Paul Grand, CEO and founder. “Over the next four months, our 2025 cohort will work closely with MTI’s extensive network of mentors and partners to advance these innovative technologies toward U.S. market access and public health benefit.”
Following a rigorous evaluation process, MTI and its corporate partners invited 213 companies (15 percent of applicants) to pitch at this year’s MedTech Innovator Road Tour events in Los Angeles, College Park, Md., and Dublin. The 65 selected cohort companies received feedback from 430 subject matter experts and represent 17 U.S. states and 13 countries.
“As a small medical device start-up company, we are excited to have been chosen to participate in MedTech Innovator’s 2025 Accelerator Cohort,” said Albert Mikhail, CEO of Multiphze. “The Multiphze Enclosed Bladder System is a game changer for medical professionals that treat hematuria patients. We look forward to learning and benefiting from the know-how and experiences represented by MTI’s world-class ecosystem of industry-leading resources and high performing peer network to prepare our company to achieve great success in the marketplace.”
About Multiphze, LLC
Multiphze is a medical device company based in Glendale, California that has developed a novel method for the management of blood-infected urine, designed to address the unmet clinical needs that have existed for decades with today’s methods and tools. Multiphze, LLC offers a patented, OSHA compliant solution for medical management of blood-tinged urine for use by urologists, ER doctors, and nursing staff.
